$2.53T
Total marketcap
$191.06B
Total volume
BTC 50.00%     ETH 15.86%
Dominance

Nuvalent NUVL Stock

78.11 USD {{ price }} -3.329211% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
5B USD
LOW - HIGH [24H]
78.05 - 80.63 USD
VOLUME [24H]
382.38K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.17 USD

Nuvalent Price Chart

Nuvalent NUVL Financial and Trading Overview

Nuvalent stock price 78.11 USD
Previous Close 43.08 USD
Open 42.92 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 42.74 - 45.25 USD
52 Week Range 9.45 - 45.25 USD
Volume 314.92K USD
Avg. Volume 280.1K USD
Market Cap 2.54B USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -2.17 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 46.75 USD

NUVL Valuation Measures

Enterprise Value 2B USD
Trailing P/E N/A
Forward P/E -16.071943
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 5.711364
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Nuvalent Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 345.90%
S&P500 52-Week Change 20.43%
52 Week High 45.25 USD
52 Week Low 9.45 USD
50-Day Moving Average 37.31 USD
200-Day Moving Average 29.55 USD

NUVL Share Statistics

Avg. Volume (3 month) 280.1K USD
Avg. Daily Volume (10-Days) 276.27K USD
Shares Outstanding 51.39M
Float 22.66M
Short Ratio 14.68
% Held by Insiders 4.43%
% Held by Institutions 104.37%
Shares Short 3.89M
Short % of Float 31.14%
Short % of Shares Outstanding 6.83%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -16.70%
Return on Equity (ttm) -25.10%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -89497000 USD
Diluted EPS (ttm) -1.71
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 450.46M USD
Total Cash Per Share (mrq) 7.93 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 26.808
Book Value Per Share (mrq) 7.823

Cash Flow Statement

Operating Cash Flow (ttm) -75843000 USD
Levered Free Cash Flow (ttm) -43347752 USD

Profile of Nuvalent

Country United States
State MA
City Cambridge
Address One Broadway
ZIP 02142
Phone 857 357 7000
Website https://www.nuvalent.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 70

Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase ½ clinical trial; and NVL-330, a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to treat tumors driven by HER2ex20, brain metastases, and avoiding treatment-limiting adverse events including due to off-target inhibition of wild-type EGFR, which is ongoing IND-enabling studies. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Q&A For Nuvalent Stock

What is a current NUVL stock price?

Nuvalent NUVL stock price today per share is 78.11 USD.

How to purchase Nuvalent stock?

You can buy NUVL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Nuvalent?

The stock symbol or ticker of Nuvalent is NUVL.

Which industry does the Nuvalent company belong to?

The Nuvalent industry is Biotechnology.

How many shares does Nuvalent have in circulation?

The max supply of Nuvalent shares is 64.07M.

What is Nuvalent Price to Earnings Ratio (PE Ratio)?

Nuvalent PE Ratio is now.

What was Nuvalent earnings per share over the trailing 12 months (TTM)?

Nuvalent EPS is -2.17 USD over the trailing 12 months.

Which sector does the Nuvalent company belong to?

The Nuvalent sector is Healthcare.

Nuvalent NUVL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD